InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Mammen Mathai, Director. Director active across 2 companies, notably 10x Genomics, Inc.. Aggregated, 6 reports have been recorded. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
02,120 shares0
Class A Common Stock
SEC:0001567619-22-013119:0·
07,740 shares0
Common Stock
SEC:0001225208-22-002372:0·
07,740 shares0
Common Stock
SEC:0001225208-22-002372·
07,418 shares0
Common Stock
SEC:0001225208-22-002220:0·
0625 shares0
Class A Common Stock
SEC:0001209191-21-040689·
0625 shares0
Class A Common Stock
SEC:0001209191-21-040689:0·
6 of 6 declarations
About Mammen Mathai
Mathai Mammen is a Board Member and Executive Vice President of Pharmaceuticals and R&D at 10x Genomics, Inc. and JOHNSON & JOHNSON. He plays an essential role in the research and innovation strategy of these companies.
